Surat Samachar

Nuclear Medicine Market to Hit USD 18.9 Bn by 2029: Competitive Landscape, Industry Analysis, New Opportunities, Dynamics and Regional Insights

 Breaking News
  • No posts were found

Nuclear Medicine Market to Hit USD 18.9 Bn by 2029: Competitive Landscape, Industry Analysis, New Opportunities, Dynamics and Regional Insights

April 06
18:08 2023
Nuclear Medicine Market to Hit USD 18.9 Bn by 2029: Competitive Landscape, Industry Analysis, New Opportunities, Dynamics and Regional Insights
Nuclear Medicine Market
The Nuclear Medicine Market size was valued at USD 5.5 Bn. in 2021 and the total Insulation revenue is expected to grow by 14.7 % from 2022 to 2029, reaching nearly USD 18.9 Bn.

Pune 6, April 2023: The report expects the Nuclear Medicine Market to grow from USD 5.5 Bn in 2021 to USD 18.9 Bn by 2029 at a CAGR of 14.7 percent over the forecast period. The report is a mixture of primary data and secondary data and domain expert has analyzed the Nuclear Medicine Market from a local, global and regional perspective.

Nuclear Medicine Market Report Scope and Research Methodology

The report includes the current trends and market highlights in the Nuclear Medicine market. It provides the major drivers, challenges, and restraints of the market. The report covers the estimation of the Nuclear Medicine market size and growth rate of the market investors and stakeholders perceive the investment decisions with the demand and pricing analysis of the market. Segment-wise analysis of the market is divided into Product Type, Application and End-User.

Regional analysis of the market is conducted at a global, regional and country level and it helps the regional insights such as market share dominance, market penetration and upcoming market growth opportunities. The bottom-up approach was used for Nuclear Medicine market size estimation. Primary and secondary data collection techniques with qualitative and quantitative analysis are used for the collection of data for the market. SWOT analysis was conducted to provide the strengths and weaknesses of the Nuclear Medicine industry while PESTLE was employed to understand the growth targets and risks of the market.

Nuclear Medicine Market Dynamics 

The Nuclear Medicine Market is driven by the increasing number of incidences of cardiovascular disease (CVD) and cancer, the growing geriatric population, increasing research and developments healthcare sector and the emergence of high-resolution diagnostic techniques such as SPECT, CT and PET. The increasing initiatives for reducing the demand-supply gap of Mo-99 and favorable government initiatives for nuclear medicine are also responsible growth factors for the Nuclear Medicine industry. 

The increasing use of radiopharmaceuticals in neurological applications is the expected lucrative opportunity for the growth of the Nuclear Medicine Market. The market growth is constrained by the short half-life of radiopharmaceuticals.   

Get a Sample Copy of the Report: 

Nuclear Medicine Market Regional Insights

In 2021, North America dominated the Nuclear Medicine Market with a market share of 45.2 percent and is expected to continue its dominance over the forecast period.  The regional market is driven by government funding, strong healthcare infrastructure, increasing prevalence of cancer and the development of novel technologies for the production of the radioisotope. 

Asia Pacific region is expected to have a significant growth rate for the Nuclear Medicine Market. The increasing use of nuclear medicine, rising healthcare expenditure increasing prevalence of cardiovascular disorders are the expected influencing factors for the regional growth of the market. 

Nuclear Medicine Market Segmentation

By Product Type

  • Diagnostic Radiotherapeutics
  • Therapeutic Radiotherapeutics


By Application

  • Neurology
  • Oncology
  • Cardiology
  • Others


By End-User

  • Hospitals
  • Clinical Laboratories
  • Diagnostic Centers
  • Others


Nuclear Medicine Market Key Players include:

  • Cardinal Health Inc (US)
  • GE HealthCare Technologies Inc (US)
  • Jubliant Lifesciences (US)
  • Lantheus Medical Imaging Inc. (US)
  • Biodex Medical Systems, Inc. (US)
  • Standard Imaging Inc. (US)
  • Digirad Corporation (US)
  • CMR Naviscan (US)
  • Nordion Inc. (Canada)
  • Bayer AG (Germany)
  • Siemens Healthineers (Germany)
  • SurgicEye GmbH (Germany)
  • Curium (France)
  • Advanced Accelerator Applications (France)
  • Mallinckrodt Pharmaceuticals (UK)
  • Bartec Technologies Ltd. (UK)
  • Norgine B.V. (Netherland)
  • Medtronic plc (Ireland)
  • DDD-Diagnostic A/S (Denmark)
  • Mediso Ltd. (Hungary)
  • Neusoft Corporation (China)
  • Canon Medical Systems Corporation (Japan)
  • FUJIFILM Holdings Corporation (Japan)
  • Cyclopharm (Australia)
  • Bozlu Holding A.Ş (Turkey)


Table of Content for Global Nuclear Medicine Market:

  • Global Nuclear Medicine Market: Research Methodology
  • Global Nuclear Medicine Market: Executive Summary
  • Market Overview and Definitions
  • Introduction to the Global Market
  • Summary
  • Key Findings
  • Recommendations for Investors
  • Recommendations for Market Leaders 
  • Recommendations for New Market Entry 
  • Global Nuclear Medicine Market: Competitive Analysis 
  • MMR Competition Matrix
  • Market Structure by Region
  • Competitive Benchmarking of Key Players
  • Consolidation in the Market
  • M&A by region
  • Key Developments by Companies
  • Market Drivers
  • Market Restraints
  • Market Opportunities 
  • Market Challenges
  • Market Dynamics
  • PORTERS Five Forces Analysis
  • Regulatory Landscape by region
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America
  • COVID-19 Impact
  • Global Nuclear Medicine Market Segmentation
  • Global Market, by Product Type (2021-2029)
  • Global Market, by Application (2021-2029)
  • Global Market, by End-User (2021-2029)
  • Regional Global Nuclear Medicine Market(2021-2029)
  • Regional Market, by Product Type (2021-2029)
  • Regional Market, by Application (2021-2029)
  • Regional Market, by End-User (2021-2029)
  • Regional Market, by Country (2021-2029)
  • Company Profile: Key players 
  • Company Overview
  • Financial Overview
  • Global Presence
  • Capacity Portfolio
  • Business Strategy 
  • Recent Developments

Get the Sample PDF of Report: 

Key questions answered in the Nuclear Medicine Market are:

  • What is Nuclear Medicine?
  • What was the Nuclear Medicine market size in 2021?
  • What is the expected Nuclear Medicine market size by 2029?
  • What are the different segments of the Nuclear Medicine Market?
  • What are the factors restraining the growth of the Nuclear Medicine Market?
  • What is the scope of the Nuclear Medicine Market?
  • What is the growth rate of the Nuclear Medicine Market?
  • Which are the factors expected to drive the Nuclear Medicine market growth?
  • What are the major challenges that the Nuclear Medicine Market could face in the future? 
  • What segments are covered in the Nuclear Medicine Market?
  • What are the key players in the Nuclear Medicine Market?
  • What are the opportunities for the Nuclear Medicine Market?

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2021)
  • Past Pricing and price curve by region (2018 to 2021)
  • Market Size, Share, Size & Forecast by different segment | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis of the Product Type, Application, End-User and Region 
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective 
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis 
  • PORTER’s analysis 
  • Value chain and supply chain analysis 
  • Legal Aspects of Business by Region

Maximize Market Research Healthcare research firm, has also published the following reports:

Therapeutic Nuclear Medicine MarketThe market size is expected to reach USD 6.74 Bn by 2029 at a CAGR of 4.7 percent during the forecast period. The market is driven by the increasing growth rate of disease, the growing prevalence of cardiovascular diseases and advances in cancer treatments and radiotracers.

Nuclear Medicine Equipment Market: The market size is expected to reach USD 3.56 Bn by 2029 at a CAGR of 3.87 percent during the forecast period. The market is driven by the rising cancer prevalence and increasing adoption of nuclear medicine appliances by end users.

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected] 

+91 96071 95908, +91 9607365656

Media Contact
Contact Person: Geeta Yevle
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India